Collaborating Authors

Cancer's 'internal wiring' predicts relapse risk

BBC News

The "internal wiring" of breast cancer can predict which women are more likely to survive or relapse, say researchers. The study shows that breast cancer is 11 separate diseases that each has a different risk of coming back. The hope is that the findings, in the journal Nature, could identify people needing closer monitoring and reassure others at low risk of recurrence. Cancer Research UK said that the work was "incredibly encouraging" but was not yet ready for widespread use. The scientists, at the University of Cambridge and Stanford University, looked in incredible detail at nearly 2,000 women's breast cancers.

'Treatment may extend advanced breast cancer survival'

BBC News

Combining a pioneering drug with hormone therapy may extend the survival of some women with advanced breast cancer, a trial suggests. Women who received palbociclib and hormone therapy lived up to 10 months longer than those given hormone treatment alone. It also delayed the time at which women needed to begin chemotherapy, which often has debilitating side-effects. Experts say the preliminary results of the trial are very encouraging. But they point out that the treatment is not a cure and will not work for everyone.

Dr. Marc Siegel: Incredible new discoveries can use your genes to create personalized medical care

FOX News

Doctors use genetic testing to gauge whether a woman with breast cancer can skip chemotherapy. Breast cancer is by far the most common cancer among women in the United States and around the world. About 12 percent of women in the U.S. will develop invasive breast cancer in their lifetimes. Doctors are working hard to better understand this life-threatening disease. Their goal is to find new and more effective ways to treat the more than 266,000 American women diagnosed with invasive breast cancer each year in the United States with the least amount of harmful side effects possible, while at the same time preventing the spread or recurrence of the disease.

Breast cancer: One-dose radiotherapy 'as effective as full course'

BBC News

A single targeted dose of radiotherapy could be as effective at treating breast cancer as a full course, a long-term study suggests. Researchers said people who received the shorter treatment were also less likely to die of other cancers and heart disease in the following five years. But cancer specialists have raised concerns about the study's methodology. A fifth of patients in the study received extra doses of radiotherapy. The study's lead author, Prof Jayant Vaidya, said he had expected a proportion of the women to need extra radiotherapy, since post-op tests could reveal tumours were bigger or more aggressive than expected.

Breast cancer victims are missing out on a life-saving pill that costs 34p a day

Daily Mail - Science & tech

Thousands of women with breast cancer are being needlessly denied life-saving pills that cost 34p a day, experts warn. Thousands of women with breast cancer are being needlessly denied life-saving pills that cost 34p a day, experts warn. An estimated 27,000 women a year are missing out on bisphosphonates – a drug that stops breast cancer spreading to the bones. If everyone who could benefit from the drugs received them, 1,180 lives could be saved a year in England, according to charity Breast Cancer Now. And its research revealed a lack of clear guidance on funding them was the main obstacle to prescriptions.